All News about Acorda TherapeuticsFrom Acorda Therapeutics
Via Business Wire
Acorda Shareholders Invited to Virtual Q&A with CEO Ron Cohen, M.D.
October 21, 2022
From Acorda Therapeutics
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536